Lipoatrophy, localized after injections T88.7

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 21.12.2021

Dieser Artikel auf Deutsch

Synonym(s)

Insulin Lipoatrophy; Lipodystrophy

Definition
This section has been translated automatically.

Side effect in the area of insulin injection sites in diabetics with partly massive skin atrophies 6 months to 2 years after the onset of the insulin response. Lipoatrophies are not only cosmetically disturbing, but can also considerably disturb the absorption kinetics of insulinand cause hyper- or hypoglycemia.

Etiopathogenesis
This section has been translated automatically.

Mainly occurring with the use of insulins with an acidic pH value. Protein impurities contained in insulin are also a conceivable cause. Furthermore, localized drug-induced lipatrophies are observed after injections of glucocorticoids and MS drugs (glatiramer acetate - regular side effect in women).

Manifestation
This section has been translated automatically.

Mainly occurring in women and children.

Localization
This section has been translated automatically.

injection sites, exceptionally also far from the injection sites.

Therapy
This section has been translated automatically.

Changing injection sites. Changing the insulin preparation. Use of a neutral insulin or a monocomponent insulin. S.a.u. Insulin lipoma.

Progression/forecast
This section has been translated automatically.

Spontaneous regression within years.

Literature
This section has been translated automatically.

  1. Balak DM et al(2012) Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review. Mult Scler 18:1705-1717

Incoming links (1)

Insulin lipoatrophy;

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 21.12.2021